A Multicenter, Randomized and Controlled Trial for Chang-An-Jun-Tai Granule in the Treatment of Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D).

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine0 sitesTBD

Overview

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

3 years ago

Study Type

Interventional study

Sex

All

Sponsor

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

•To simultaneously satisfy the following criteria:
•1\. Conform to the Roman IV(Rome IV) of a patient diagnosed with IBS\-D and baseline IBS\-SSS score \> 75;
•2\. Aged 18 to 60 years;
•3\. Nearly 2 weeks no using the drugs in the treatment of IBS;
•4\. Nearly 2 weeks no using antibiotics or probiotics;
•5\. The patients volunteered to receive the drug and signed an informed consent form, and the informed consent process was in accordance with the relevant provisions of GCP.

•Meet one of the following criteria were excluded:
•1\. there is explanation above the clinical symptoms of the patients with other diseases;
•2\. chronic esophagitis, Barrett esophagus and gastroesophageal reflux disease, peptic ulcer, gastric polyp (without resection), digestive tract tumor patients;
•3\. found that endoscopic gastric mucosa high grade intraepithelial neoplasia, pathological diagnosis, malignant gastrointestinal organic diseases;
•4\. patients with history of abdominal operation;
•5\. allergic or allergic to many medicines;
•6\. confusion, dementia, psychosis, neurosis and various serious unwilling to cooperate;
•7\. with serious the primary cardiovascular disease, liver disease, kidney disease, blood disease, lung disease, autoimmune diseases, or serious diseases affected the survival, such as cancer or aids;
•8\. pregnant and lactating women;
•9\. exist cognitive or other damage (such as vision, etc.) and impact on the participants completed self\-report;

Not specified